Technical Analysis for INSY - Insys Therapeutics, Inc.

Grade Last Price % Change $ Change
grade D $12.35 2.66% 0.32
INSY closed up 2.66 percent on Monday, February 27, 2017, on 64 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical INSY trend table...

Date Alert Name Type % Chg
Feb 27 NR7 Range Contraction 0.00%
Feb 27 Calm After Storm Range Contraction 0.00%
Feb 24 New Uptrend Bullish 2.66%
Feb 24 Upper Bollinger Band Walk Other 2.66%
Feb 24 Slingshot Bullish Bullish Swing Setup 2.66%
Feb 24 Calm After Storm Range Contraction 2.66%
Feb 23 Downside 200 DMA Break Bearish -3.52%
Feb 23 Stochastic Sell Signal Bearish -3.52%
Feb 23 Upper Bollinger Band Walk Other -3.52%
Feb 22 Upside 200 DMA Break Bullish -8.38%

Older signals for INSY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
View chart:

Profile
INSYS Therapeutics, Inc., a development stage company, develops pharmaceutical products that target the unmet needs of cancer patients, with a focus on cancer-supportive care. The company’s cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray, a single-use product for the treatment of breakthrough cancer pain; and Dronabinol SG capsule, an ANDA approved product and Dronabinol Oral Solution, which completed Phase II clinical trials for the treatment of chemotherapy-induced nausea and vomiting, and appetite stimulation in AIDS patients. It also develops proprietary cancer therapeutics comprising LEP-ETU, a NeoLipid liposomal, which is in Phase II clinical development stage to enhance efficacy and reduce paclitaxel-related side effects. The company was founded in 2002 and is based in Phoenix, Arizona.
Is INSY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 21.22
52 Week Low 8.7
Average Volume 1,121,732
200-Day Moving Average 12.89
50-Day Moving Average 10.17
20-Day Moving Average 10.71
10-Day Moving Average 11.51
Average True Range 0.73
ADX 26.56
+DI 34.36
-DI: 12.85
Chandelier Exit (Long, 3 ATRs) 11.5
Chandelier Exit (Short, 3 ATRs) 11.49
Upper Bollinger Band 13.15
Lower Bollinger Band 8.27
Percent B (%b) 0.84
Bandwidth 0.455649